🔗 Share this article

A shadow economy for unlicensed weight-loss medications is propelled by social media fitness personalities and vendors on communication apps, based on recent findings.

Investigational Treatment Acquiring Traction Online

Retatrutide, which remains in research studies, is being promoted by online personalities for its supposed fat-burning properties. Viewers are urged to message these profiles directly for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Separately, a robust market exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and assertions of next-day UK delivery. Sellers promote the drug there before directing customers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Express Worries

Nevertheless, physicians and pharmacists have warned that the sale of what remains an unapproved medication in the UK is worrisome and could lead to users administering substances of uncertain source.

Several professionals said the demand for the experimental drug could be linked to the rising price of approved weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the British medical regulations.

Several influencers try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate pharmaceutical, advertising, and customer regulations, potentially leading to fines, prosecution or imprisonment.

Platform Response and Material Removal

Based on TikTok, the platform has taken down problematic material and banned related hashtags and query recommendations. The company said it was dedicated to maintaining the service secure and investing in enhancing enforcement strategies.

Digital Marketplace Activities

Investigations also discovered communities with up to 9,000 members selling retatrutide using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately brings up channels with thousands of users, populated with photos of slimming results, positive reviews and step-by-step guides for preparing or injecting at home.

Within moments of joining one community, a vendor posted contact information, where most purchases take place. The vendor provided an guidebook and guaranteed shipping within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about weight, medical conditions or past usage.

Item Details and Costs

Inside these groups, posts display black plastic packages with postal service stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When asked how much time a pen should be used, vendors give conflicting responses ranging from a few weeks to “depends on your body”.

Service Oversight and Security Measures

A representative for the messaging service stated it regularly monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering substances they cannot confirm. Although the science behind this drug is sound, these online versions may not contain what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in interest to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.

Her team has previously encountered individuals injured by personal administration from unconfirmed sources. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a company investigational product not yet authorized … may subject users to possibly significant health risks”.